Emílio Pizzichini

General Medical Council — United Kingdom

Medicine · Health Sciences

45h-index14.8kcitations190works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(140), Chronic Obstructive Pulmonary Disease (COPD) Research(71), Respiratory and Cough-Related Research(69), Inhalation and Respiratory Drug Delivery(49), Respiratory Support and Mechanisms(18)

Publications190 total

Misconceptions of Traits to Predict Response to Inhaled Corticosteroid and Bronchodilator Therapies in Asthma: A Narrative Review
Pulmonary Therapy·2025Open Access
Regional challenges to optimize the management of patients with severe asthma type 2 inflammation: a Delphi consensus in seven countries
Journal of Asthma·2025· 1 citedOpen Access
Is asthma remission an important clinical outcome in asthma management?
European Respiratory Journal·2024· 1 cited
Is asthma mortality decreasing or increasing in Brazil? The burden of proof
Jornal Brasileiro de Pneumologia·2024Open Access
Run-in periods and treatment outcomes in asthma trials: A narrative review
Contemporary Clinical Trials Communications·2024· 1 citedOpen Access
Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study
The Journal of Allergy and Clinical Immunology In Practice·2024· 4 citedOpen Access
Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study
The Journal of Allergy and Clinical Immunology In Practice·2024· 4 citedOpen Access
Multi-country self-controlled study of exacerbation rates in severe asthma patients treated with mepolizumab: NEST interim analysis
2023
Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma
CHEST Journal·2023· 26 citedOpen Access
Baseline Characteristics of Patients With Severe Asthma Treated With Mepolizumab: An Interim Analysis of a Multi-country Real-world Cohort
2023· 1 cited
Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study
Frontiers in Immunology·2023· 104 citedOpen Access
Consensus on mild asthma management: results of a modified Delphi study
Figshare·2023Open Access
Le traitement par mépolizumab permet d’atteindre la rémission clinique chez les patients atteints d’asthme sévère à éosinophiles : résultats de l’étude en vie réelle REDES
Revue des Maladies Respiratoires Actualités·2023
Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis
Respiratory Medicine·2022· 7 citedOpen Access
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study
The Lancet Respiratory Medicine·2022· 60 citedOpen Access
Celebrating World Asthma Day in Brazil: lessons learned from the pandemic. Can we do better?
Jornal Brasileiro de Pneumologia·2022· 1 citedOpen Access
Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic
Advances in Therapy·2022· 14 citedOpen Access
Consensus on mild asthma management: results of a modified Delphi study
Journal of Asthma·2022· 12 citedOpen Access
Towards Optimum Reporting of Pulmonary Effectiveness Databases and Outcomes (TORPEDO): identifying a core dataset for asthma and COPD studies
2021Open Access
CAPTAIN: EFFECTS OF AGE AS A CONTINUOUS VARIABLE ON TREATMENT OUTCOMES
CHEST Journal·2021
page 1 of 10Next →

Frequent Co-authors

Márcia Margaret Menezes Pizzichini(19), Ann Efthimiadis(12), Jerry Dolovich(12), F.E. Hargreave(8), Frederick E. Hargreave(6), P Hussack(6), F. E. Hargreave(5), Alberto Papi(5), Klaus F. Rabe(5), MM Pizzichini(5), Todor A. Popov(5), David Price(5), Alison Chisholm(5), Paul M. O’Byrne(4), Pierluigi Paggiaro(4), Ian Pavord(4), Dirkje S. Postma(4), Eric D. Bateman(3), Leonardo M. Fabbri(3), Ratko Djukanović(3)